Logos Global Management LP is > 10% Shareholder of Verve Therapeutics, Inc.. Currently has a direct ownership of 370,000 shares of VERV, which is worth approximately $1.94 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 370,000 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $7,030,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 370K
0% 3M change
0% 12M change
Total Value Held $1.94 Million

Logos Global Management LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2021
BUY
Open market or private purchase
$7,030,000 $19.0 p/Share
370,000 Added 50.0%
370,000 Common Stock

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
LGM

Logos Global Management LP

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on VERV

Follow Verve Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

News

Receive news related to Verve Therapeutics, Inc.

Track Activities on VERV